Frederick Feuerstein
Family Medicine · Omaha, NENPI 1578678413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,359 and has fallen 94.4% since, to $76 in 2022.
Across 156 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$474
- Boehringer Ingelheim$333
- Johnson & Johnson$288
- AbbVie$273
- Novo Nordisk$195
- Amgen$182
- plus $846 from 20 others
What the payments were for
- Food & beverage$2,585100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $474 |
| Boehringer Ingelheim | 25 | $333 |
| Johnson & Johnson | 13 | $288 |
| AbbVie(2 entities) | 19 | $273 |
| Novo Nordisk | 14 | $195 |
| Amgen | 11 | $182 |
| Lilly USA, LLC | 9 | $117 |
| Pfizer | 7 | $99 |
| Sanofi-aventis U.S. LLC | 5 | $76 |
| Merck | 5 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $66 |
| Eisai Inc. | 4 | $50 |
| Amarin Pharma, Inc. | 3 | $46 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Medicure Pharma Inc. | 1 | $39 |
| Bayer | 3 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Abbott | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Kowa Pharmaceuticals America, Inc. | 2 | $22 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| GSK | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$123
- FARXIGA$115
- SYMBICORT$115
- BREZTRI AEROSPHERE$115
How this compares
$2,591 in reported general payments places this provider in the 80th percentile of 981 family medicine providers in Nebraska.
Other family medicine in Omaha
- Gerard StanleyOmaha$50K
- Yongge LiuOmaha$15K
- M DadaOmaha$14K
- Christopher ConnollyOmaha$12K
- Paul VanaOmaha$12K
- Stephen TetraultOmaha$11K
- James RamigOmaha$11K
- Jeffrey RappOmaha$10K
- Christine Carlson RahnOmaha$10K
- Joseph DumbaOmaha$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.